42
Scientific research and development services, namely, laboratory research and monitoring of clinical trials for diagnostic tests for drug screening, instruments for drug screening, and pharmaceuticals, laboratory research and monitoring of clinical trials in the field of activity-based proteomics scientific and technological services for applying proprietary chemical technologies and high-throughput protein analysis to drug discovery processes and research and design relating thereto, scientific and technological services for drug development and discovery, scientific and technological services for addressing disease mechanisms with focus on functional proteins and research and design relating thereto, scientific and technological services for selectivity profiling drug candidates across protein families in biological samples to guide their medicinal chemistry optimization and research and design relating thereto, scientific and technological services to identify novel drug targets and biomarkers and research and design relating thereto, and scientific and technological services to characterize off-target activities of candidate and established drugs to understand the basis for their efficacy and toxicity and research and design relating thereto
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen